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Aims During b-adrenergic receptor (b-AR) stimulation, phosphorylation of cardiomyocyte ryanodine receptors by protein
kinases may contribute to an increased diastolic Ca2+ spark frequency. Regardless of prompt activation of
protein kinase A during b-AR stimulation, this appears to rely more on activation of Ca2+/calmodulin-dependent
protein kinase II (CaMKII), by a not yet identified signalling pathway. The goal of the present study was to identify
and characterize the mechanisms which lead to CaMKII activation and elevated Ca2+ spark frequencies during b-AR
stimulation in single cardiomyocytes in diastolic conditions.
Methods
and results
Confocal imaging revealed that b-AR stimulation increases endogenous NO production in cardiomyocytes, resulting in
NO-dependent activation of CaMKII and a subsequent increase in diastolic Ca2+ spark frequency. These changes of spark
frequency could be mimicked by exposure to the NO donor GSNO and were sensitive to the CaMKII inhibitors KN-93
and AIP. In vitro, CaMKII became nitrosated and its activity remained increased independent of Ca2+ in the presence of
GSNO, as assessed with biochemical assays.
Conclusions b-AR stimulation of cardiomyocytes may activate CaMKII by a novel direct pathway involving NO, without requiring
Ca2+ transients. This crosstalk between two established signalling pathways may contribute to arrhythmogenic diastolic
Ca2+ release and Ca2+ waves during adrenergic stress, particularly in combination with cardiac diseases. In addition,
NO-dependent activation of CaMKII is likely to have repercussions in many cellular signalling systems and cell types.
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1. Introduction
In cardiac excitation–contraction coupling Ca2+-induced Ca2+ release
(CICR) is the mechanism that amplifies the Ca2+ signal initiated by entry
of Ca2+ via voltage-dependent Ca2+ channels.1 During each systole,
CICR generates a robust Ca2+ transient by releasing Ca2+ from the
sarcoplasmic reticulum (SR) via Ca2+ release channels (a.k.a. ryanodine
receptors or RyRs). These are macromolecular complexes located in
diadic clefts, microdomains of junctional SR, in close apposition to
L-type Ca2+ channels.2 Each group of RyRs and L-type Ca2+ channels
forms a unit called couplon which can create elementary Ca2+ release
events, Ca2+ sparks.3 Faithful RyR functioning is crucial in the context
of cardiac muscle Ca2+ release, its synchronization, and strength of con-
traction. Disturbances of these elementary mechanisms have been
observed during various cardiac pathologies.4,5
Upon b-adrenergic receptor (b-AR) stimulation during emotional
stress or physical exercise, key proteins of Ca2+ signalling, such as the
L-type Ca2+ channels, the RyRs, and phospholamban are phosphory-
lated by protein kinases,6,7 enhancing Ca2+ cycling. There is recent evi-
dence indicating that elevated phosphorylation levels of the RyR
mediated by protein kinase A (PKA) and Ca2+/calmodulin-dependent
protein kinase II (CaMKII) may increase their activity8– 11 (for reviews
see refs7,12). During chronic b-AR stimulation, this could constitute a
Ca2+ leak and deplete the SR of Ca2+, which would reduce the ampli-
tude of Ca2+ transients, eventually contributing to weak heartbeats.13
Experimentally, it has proven difficult to clearly assign a role for the
different kinases in modulating RyR behaviour. The generation of
various transgenic mouse lines, specifically targeting phosphorylation
by PKA and CaMKII, has not clarified the situation and provided appar-
ently contradictory results and interpretations. However, analysis of
Ca2+ spark frequencies in transgenic mice expressing constitutively
phosphorylated RyRs (S2808D, S2814D) suggested that PKA- and
CaMKII-dependent phosporylation may increase resting Ca2+ spark
frequencies.5,9
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Here, we examined Ca2+ sparks as signals closely reflecting RyR open
probability in their native environment. While there is controversial lit-
erature on the relative importance of PKA- and/or CaMKII-dependent
RyR phosphorylation,8,14 only few studies specifically investigated
changes of Ca2+ spark frequencies resulting from b-AR stimulation
during diastole or in resting cardiomyocytes.5,9,15,16 Based on these find-
ings, it hasbeen suggested thatPKA-dependentphosphorylation of RyRs
may not be significantly involved in the observed increase in the resting
Ca2+ spark frequency. It has been reported that this entirely hinged on
the SERCA stimulation resulting from phosphorylation of phospholam-
ban17 or occurred via a pathway that could involve CaMKII.14,16,18– 20
Since the CaMKII-dependent increase in spontaneous spark frequencies
was observed in resting cardiomyocytes without detectable Ca2+
signals, which are typically required for significant Ca2+-dependent acti-
vation of CaMKII,21,22 it remained unresolved by which pathway(s)
CaMKII would become activated under these conditions.
The current study represents an effort to reveal the mechanism
involved in the activation of CaMKII in resting cardiomyocytes during
b-AR stimulation and to identify an alternative pathway that could
underlie the observed increase in Ca2+ spark frequency.
In the literature, several possible mechanisms have been mentioned.
The ‘exchange protein activated by cAMP’ (Epac) may participate in
the modulation of RyR open probability, either directly or via
CaMKII.18 Another alternative is activation of CaMKII by reactive
oxygen species (ROS), which is known to occur independently of de-
tectable Ca2+ signals.23 Therefore, we carried out experiments investi-
gating Ca2+ sparks and CaMKII activity to characterize the putative
involvement of these and other cellular signalling pathways.
Together our findings reveal that upon b-AR stimulation, CaMKII
becomes activated in a manner that does not require Ca2+ transients,
initiated by formation of endogenous nitric oxide (NO). This represents
an unexpected and newly discovered mode of CaMKII activation occur-
ring in parallel to stimulation of PKA by cAMP. Preliminary findings have
previously been presented in the abstract form.24
2. Methods
For additional information on methods, see Supplementary material online.
2.1 Isolation ofGuinea-pig ventricularmyocytes
Forall electrophysiological and confocal Ca2+ and NO imaging experiments,
we used freshly isolated Guinea-pig ventricular cardiomyocytes16 following
the animal handling procedures conforming with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals (1996) and
with the permission of the State Veterinary Administration and according
to Swiss Federal Animal protection law (permit BE97/09). Animals were
euthanized by stunning and cervical dislocation, followed by rapid removal
and enzymatic dissociation of the cardiac tissue.
2.2 Experimental solutions
All drugs, inhibitors, and donors used during our experiments were freshly
prepared daily from aliquots. Extracellular and intracellular (patch pipette)
solutions were used from a ready-made stock.16
2.3 Electrophysiological recordings
ICa recordings were carried out in the whole-cell configuration of the patch
clamp technique, resting membrane potential was set at 280 mV during
Ca2+ imaging.16
2.4 SR Ca21 content pre-conditioning
To ensure a constant SR Ca2+ content, we performed a SR Ca2+ loading
protocol with a train of 20 membrane depolarizations from 280 to 0 mV
(Figure 1A). Pharmacological interventions were applied, as indicated.
Changes in SR Ca2+ content were compared with control conditions
without the drug, after an identical loading protocol. In all cases, content
was estimated by recording a Ca2+ transient triggered with caffeine.
2.5 Confocal Ca21 and NO imaging
The Ca2+ spark frequency and SR Ca2+ content are shown after normaliza-
tion and expressed as mean values +SEM. For these recordings, we used
fluo-3 as Ca2+ indicator. NO measurements were carried out using
DAF-2DA. Confocal imaging was performed with either a FluoView-1000
(Olympus) or a MRC-1000 confocal laser-scanning microscope (Bio-Rad).
Indicators were excited at 488 nm with a solid-state laser (Sapphire
488–10) and fluorescence was detected .515 nm.
2.6 In vitroCaMKIId activity and nitrosation
assays
Ca2+-independent, H2O2 and NO-dependent CaMKII activities were
assessed by using an ELISA kit. Values are shown normalized to the
maximal CaMKII activation levels reached in low Ca2+ (,10 nM Ca2+;
CaM/EGTA). Nitrosation of CaMKII was quantified using an antibody specif-
ically detecting S-nitrosated cysteines.
2.7 Statistics
Paired or unpaired Student’s t-tests were applied as appropriate to deter-
mine significance. In figures P-values of ,0.05 or ,0.01 are indicated by *
or **, respectively. N refers to number of animals, and n to number of cells.
3. Results
3.1 Ca21 spark frequency during b-AR
stimulation is modulated by CaMKII
but not PKA
We investigated cAMP-dependent pathways (e.g. PKA, Epac) to deter-
mine the involvement of PKA and/or CaMKII in the modulation of
resting Ca2+ spark frequencies. Constant SR loading was achieved
with Ca2+ pre-loading involving a train of L-type Ca2+ currents. SR
Ca2+ content was estimated with caffeine before and after the experi-
ment in each cardiomyocyte (Figure 1A ).16 As shown in Figure 1B and
C, superfusion of resting cells with 1 mM isoproterenol (Iso) increased
the frequency of Ca2+ sparks around 4-fold within 3 min, without signifi-
cantly altering the [Ca2+]SR in this time window (Figure 1E).
16 Next,
cAMP was raised independently of the b-AR receptors by direct activa-
tion of adenylate cyclase with forskolin.11 Surprisingly, and unlike Iso,
1 mM forskolin did not change the Ca2+ spark frequency significantly,
even though the SR content increased to 125%, presumably resulting
from SERCA stimulation without activation of sparks in parallel. Import-
antly, both drugs resulted in almost identical amplification of the L-type
Ca2+ current (ICa), confirming that forskolin activated PKA to an extent
corresponding to Iso application (Figure 1D). Inclusion of the specific
PKA inhibitory peptide PKI in the patch solution did not prevent
the increase in the Ca2+ spark frequency, but resulted in a drop of SR
Ca2+ content, presumably resulting from the suppression of SERCA
stimulation during Iso.
These results indicate that acute b-AR stimulation increases Ca2+
spark frequency, independently of cAMP and therefore makes an
involvement of PKA and Epac very unlikely. Hence, we did not follow
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up on either of these pathways. A potential alternative pathway could be
CaMKII, despite the fact that in quiescent cells, there were no Ca2+
signals that could activate this kinase. To confirm involvement of
CaMKII, as also suggested by our previous study,16 we carried out
experiments in the presence of either KN-93 or KN-92 or included
10 mM of the specific CaMKII inhibitor autocamtide-2-related inhibitory
peptide (AIP) in the patch solution. KN-93 and AIP prevented the in-
crease in Ca2+ spark frequency in Iso without changing the SR Ca2+
content (Figure 2A–C). KN-92, the inactive negative control for
KN-93, did not suppress the increase in spark frequency, as expected.
Thus, under these experimental conditions, we can use the Ca2+
spark frequency as biological indicator for CaMKII activity.
Figure1 The increase in Ca2+ spark frequencyby Iso is mediated byb-adrenergic receptors but not by cAMP. (A) The experimental protocol used trains
of depolarizations to load the SR with Ca2+ and caffeine to estimate SR Ca2+ content (for details see Supplementary material online, information). (B)
Confocal line-scan images showing Ca2+ sparks in control solution (Ctrl) and after 3 min of 1 mM Iso or 1 mM forskolin. (C) Normalized Ca2+ spark
frequency in Ctrl, after 3 min of Iso (n ¼ 8, N ¼ 8) or forskolin (n ¼ 6, N ¼ 2) and after Iso in the presence of the PKA inhibitor PKI (n ¼ 7, N ¼ 3),
respectively. In control, Ca2+ sparks are relatively indistinct and sparse in resting guinea pig cardiomyocytes16 (around 1 s21 100 mm21). While Iso led
to a 4-fold increase in Ca2+ spark frequency, this was not observed with forskolin and was not prevented by the PKA inhibitor PKI. (D) Ca2+ current
in Ctrl and after 3 min Iso or forskolin. For this experiment, the cells were held at 240 mV to inactivate Na+ currents. Normalized Ca2+ current in
Iso (n ¼ 5, N ¼ 4) or forskolin (n ¼ 6, N ¼ 5). Current stimulation by forskolin was similar to that by Iso, documenting comparable PKA activation. (E)
Typical SR Ca2+ content assessment by 10 mM caffeine. In forskolin, SR content is increased to 125+ 8.8% (n ¼ 15, N ¼ 5) because of SERCA stimulation
without activation of sparks. In contrast, in PKI the SR Ca2+ content decreased, partly because PKA inhibition prevents SERCA stimulation.
D.A. Gutierrez et al.394
3.2 ROS scavengers fail to prevent the
increase in Ca21 spark frequency
We then examined whether Ca2+-independent CaMKII activation by
ROS23 could underlie the higher spark frequency. For this, we used
Mn-TBAP, a superoxide dismutase (SOD) mimetic, which haspreviously
been shown in our experiments to reliably suppress Ca2+ sparks
initiated by oxidative stress.25 Interestingly, 100 mM Mn-TBAP failed
to prevent the increase in Ca2+ spark frequency and did not significantly
alter SR Ca2+ load (Figure 2D–F ), indicating that CaMKII activation by
b-AR stimulation is not ROS dependent.
3.3 NOmodulates Ca21 spark frequency
upon b-AR stimulation
It has been suggested that afterb-AR stimulation the increase in SR Ca2+
leak, determined with a dedicated leak protocol, is dependent on NO
production and independent of PKA, because NO-synthase (NOS) in-
hibition prevented the leak observed in the presence of Iso.11,26 To
examine whether a similar mechanism could be involved in the higher
frequency of Ca2+ spark observed here, we inhibited the synthesis of
NO while stimulating the cardiomyocytes with Iso, analogous to experi-
ments described in Figure 1. Pre-treatment with 500 mM of the NOS
Figure 2 CaMKII is involved in spark frequency modulation, but not via ROS-dependent CaMKII activation. (A) Line-scan images in Ctrl and after 1 mM
Iso, both in the presence of 10 mM of AIP in the patch pipette. (B) Ca2+ spark frequency in Ctrl and in Iso, in the absence (n ¼ 8, N ¼ 8) or presence of the
CaMKII inhibitors AIP (n ¼ 9, N ¼ 5), KN-93 (n ¼ 5, N ¼ 2), and its inactive analogue KN-92 (n ¼ 5, N ¼ 3). (C) Unchanged SR Ca2+ content in the pres-
enceofAIP,KN-93, andKN-92. (D) Line-scan images recorded after 1 hpre-incubationwith 100 mMROSscavengerMn-TBAP inCtrl andafter3 min of 1
mM Iso. (E) Ca2+ spark frequency during Iso without (n ¼ 8, N ¼ 8) and with Mn-TBAP (n ¼ 5, N ¼ 5). (F) Unchanged SR Ca2+ content in the presence of
the ROS scavenger Mn-TBAP.
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inhibitor L-NAME prevented a significant increase in Ca2+ spark
frequency (Figure 3A), indicating that upon b-AR stimulation, the spark
frequency is modulated by endogenous NO produced by NOS of the
cardiomyocyte.
To confirm NO involvement, cells were loaded with diaminofluores-
cein (DAF-2) by exposure to the ester (DAF-2DA; 0.1 mM). After appli-
cation of Iso, we recorded a substantial increase in DAF-2 fluorescence
(19+ 5%; Figure 3C and E). In some cells, the NO donor
S-nitroso-L-glutathione (GSNO; 500 mM) was added at the end of the
protocol, to confirm that DAF-2 resolves NO signals (Figure 3D).
Please note that these recordings were corrected for dye bleaching
and should not be taken quantitatively for NO concentrations.
Because DAF-2 has been reported to detect other types of reactive
species,27 we repeated the same experiment in 500 mM L-NAME to
suppress NO formation. This prevented the increase in DAF-2 fluores-
cence (Figure3E and F, orange symbols and columns), confirming that the
signal reflects NO production. Cellular ROS production induced by
GSNO was excluded with the ROS sensitive fluorescent indicator
CM-H2DCF (see Supplementary material online, Figure S1). Together,
these findings firmly establish a link between Iso-induced production
of intracellular NO by the cardiomyocytes and the observed increase
in Ca2+ spark frequencies mediated by CaMKII. This interpretation
is in line with the inability of Mn-TBAP to prevent the increase in
Ca2+ spark frequency (Figure 2D and E) and is consistent with the
observation that Mn-TBAP does not significantly scavenge NO.28
3.4 The NO donor GSNO reproduces the
increase in Ca21 spark frequency induced by
b-adrenergic stimulation
NO can affect the function of proteins, including the RyRs, via several
known pathways.29– 31 This can occur directly as post-translational
protein modifications, such as S-nitrosation (also referred to as
S-nitrosylation or transnitrosylation).12,32 Alternatively, NO can lead
Figure 3 The increase in Ca2+ spark frequency is dependent on NO. (A) Comparison of the Ca2+ spark frequency stimulation by 1 mM Iso without
(n ¼ 8, N ¼ 8) and with (n ¼ 7, N ¼ 5) 1 h pre-incubation with 500 mM L-NAME. (B) SR Ca2+ content remained unchanged in the presence of
L-NAME. (C) Representative signal of DAF-2 fluorescence before (Ctrl) and after3 min of 1 mM Iso. (D) Representative time-course of NO production
upon1 mMIso application. At theend,GSNO is applied as a positive control for NO detection. (E)Averaged time-course ofDAF-2 fluorescence in Ctrl and
during Iso recorded in the absence (red trace n ¼ 7, N ¼ 6) and presence of L-NAME (orange trace, n ¼ 6, N ¼ 4). (F) Normalized NO-induced DAF-2
fluorescence upon Iso (red bar) and after pre-incubation in 500 mM L-NAME (orange bar). L-NAME prevented the NO signal observed in control,
confirming that the DAF-2 fluorescence resulted from NO production.
D.A. Gutierrez et al.396
to the formation of cGMP and activation of protein kinase G (PKG),
which has been shown to phosphorylate RyRs, but so far only in
vitro.33 The findings in Figure 3 indicate that after Iso application, NO
mediates the increase in Ca2+ spark frequency. To support this inter-
pretation, we used a NO donor instead of Iso. One hundred fifty micro-
molar GSNO resulted in a 3.22 (+0.31)-fold increase in Ca2+ spark
frequency, thereby quantitatively mimicking the changes observed in
Iso (Figure 4A and B). Note that in these experiments, SR Ca2+
content did not maintain the control level, presumably because
GSNO increased the Ca2+ spark frequency without concomitant
SERCA stimulation (Figure 4C). To distinguish between a direct
S-nitrosation of the RyRs and an indirect modification via CaMKII (sug-
gested by the findings above), we tested whether AIP could prevent
the GSNO-dependent occurrence of sparks, similar to what was
observed in Iso. In the presence of AIP, GSNO did not significantly
elevate spark frequency (Figure 4B). These findings confirm that the
higher spark frequency in GSNO resulted largely from activation of
CaMKII and not from a direct S-nitrosation of the RyRs or activation
Figure4 The NO donor GSNO increases Ca2+ spark frequency upon CaMKII activation via nitrosation. (A) Line-scan images of Ca2+ spark recordings in
Ctrl (top), during 150 mM GSNO alone (middle), and GSNO in the presence of 10 mM AIP in the patchpipette (bottom). (B) Normalized spark frequencies
after 3 min of 1 mM Iso (blue bar n ¼ 6, N ¼ 6) and GSNO alone (red bar n ¼ 14, N ¼ 11) and with 10 mM AIP (white bar n ¼ 9, N ¼ 4). Inhibiting
CaMKII with AIP prevented the higher frequency induced by GSNO. (C) After GSNO, the SR Ca2+ content was not maintained (83+6% of control)
due to a higher spark frequency without SERCA stimulation in parallel. (D) Quantitative in vitro CaMKII activation in response to 1 mM H2O2 (blue bar)
or 500 mM GSNO (red bar) in comparison with control (white bar). CaMKII activities were normalized to full Ca2+/CaM-dependent and control activities
(N ¼ 5). (E) Detection of nitrosated CaMKII in vitro by anti-Cys-SNO specific antibody reveals increased nitrosation in GSNO.
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of PKG. In summary, these data indicate that NO can activate CaMKII, in
the absence of Ca2+ signals.
3.5 Quantification of NO-dependent
CaMKII activation in vitro
To confirm that NO could activate CaMKII in the absence of elevated
Ca2+, we used an in vitro assay.34 CaMKII activity was detected with an
ELISA test and normalized to that observed in low Ca2+ (,10 nM;
Ca2+, CaM, and EGTA, Figure 4D). As already established,23 addition of
H2O2 activated CaMKII in low Ca
2+. The activity observed in 1 mM
H2O2 was 2.65 (+0.47)-fold higher than in control. The NO donor
GSNO resulted in comparable CaMKII stimulation of 2.31 (+0.39)-fold.
CaMKII activity under these oxidative and nitrosative conditions repre-
sented 16% of the maximal Ca2+/CaM dependent activity (250 mM
Ca2 and 120 nM calmodulin). This confirms a direct activation of CaMKII
by NO, as suggested by our findings in cardiomyocytes.
Each CaMKII monomer is predicted by GPS-SNO software35 to have
three potential sites for S-nitrosation (Figure 4E, upper panel). We used
an antibody specifically recognizing S-nitrosated cysteines to quantify
CaMKII nitrosation after pre-incubation of CaMKIId with GSNO
(Figure 4E, lower panel). Indeed, a 32.1+ 13% increase of CaMKII
nitrosation was observed with this assay.
3.6 GSNO leads to arrhythmogenic
Ca21 signals in beating cardiomyocytes
At the cellular level, spontaneous Ca2+ waves (SCWS) are considered
to be indicators for arrhythmogenic conditions. Since the elevated
Ca2+ spark frequencies shown above could result in SCWS, we tested
the arrhythmogenic potential of the NO donor in field stimulated cardi-
omyocytes (Figure 5). In these experiments, NO presumably modified
several relevant Ca2+ signalling proteins and membrane channels.
However, the recordings revealed an increase in the diastolic Ca2+
spark frequency, similar to what was observed in resting cells. Further-
more, after a train of 10 depolarizations, 13.3% of the control myocytes
exhibited SCWS, while in the presence of GSNO 77.8% showed waves.
This elevatedwave frequencywasaccompaniedbya reducedSRcontent
(to 77+6.5% of control), confirming that the waves were resulting
from altered function of the RyRs and not from SR Ca2+ overload.
Taken together, our results provide compelling evidence that the
observed increase in Ca2+ spark frequency upon b-AR stimulation
results from an activation of CaMKII, which is mediated by NO but is
not dependent on Ca2+ transients (see Figure 6 for a diagram of this
pathway). This represents a new mechanism for CaMKII activation
that may have far reaching implications.
Figure5 In beating cardiomyocytes, the NO donor GSNO increased
diastolic Ca2+ spark frequency and induced arrhythmogenic diastolic
Ca2+ waves. (A) Protocol used to record Ca2+ transients and Ca2+
waves from myocytes during and immediately after stimulation, with
or without the presence of GSNO. (B) GSNO resulted in more diastolic
Ca2+ sparks,(C) in a higher propensity for spontaneous Ca2+ waves
(SCWS) and (D) in reduced SR Ca2+ content. (E) Statistical analysis of
SCWS (n ¼ 9, N ¼ 5) and SR content (n ¼ 9, N ¼ 5).
Figure6 Diagram of the involved pathways duringb-AR stimulation
of resting cardiomyocytes. Our results show that duringb-AR stimula-
tion by Iso, endogenous production of NO derived fromNOS activates
CaMKII and subsequently modulates the RyRs open probability, as
reflected by the higher Ca2+ spark frequency.
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4. Discussion
RyRs have attracted considerable research interest, due to discoveries
such as RyR mutations causing life-threatening arrhythmias.36 Altera-
tions of their behaviour are observed during several diseases and are
often caused by post-translational modifications, most notable
phosphorylation and oxidation/nitrosation (for review see ref.12). The
participation of the RyRs in diseases such as catecholaminergic poly-
morphic ventricular tachycardias (CPVTs) and heart failure suggests
that they may be potential drug targets.37,38
4.1 Modulation of RyR function
Changes of RyR function are expected to have a significant impact on
cardiac Ca2+ signalling. Several laboratories have examined functional
consequences of RyR phosphorylation on various levels of complexity,
from single channels to isolated cells, partly using transgenic animal and
disease models.7,39,40 These studies have resulted in a considerable con-
troversy and confusion regarding the functional role of the involved
protein kinases PKA and CaMKII.14,41 The reasons for this are not
clear, butmayarise fromdifferent diseasemodels, protocols, andexperi-
mental designs. As suggested by the present study, they may partly arise
from unexpected cross-talks between complex cellular signalling path-
ways.
4.2 Modes of CaMKII activation
When examining the importance of protein kinases for changes of dia-
stolic Ca2+ spark frequencies afterb-AR stimulation, we made a surpris-
ing observation. Even though therewerenovisible Ca2+ signals in resting
cells that could lead to significant CaMKII activation, the increase in Ca2+
spark frequencies could be prevented by pharmacologically blocking
CaMKII (but not PKA). This immediately raised the question how
under these circumstances CaMKII could become activated? In the lit-
erature, several possibilities have been reported, including a pathway in-
volving ‘exchange factor directly activated by cAMP’ (Epac),15,42 or
requiring oxidative modification of the CaMKII.23 The observation that
the application of forskolin did not elevate the propensity of diastolic
Ca2+ sparks, unlike b-AR stimulation, is in line with our conclusion,
based on the experiments with protein kinase inhibitors for CaMKII
and PKA, that any PKA involvement is highly unlikely. Furthermore,
the negative result with forskolin regarding spark frequencies makes ac-
tivation of CaMKII via the Epac pathway improbable and is consistent
with the finding that forskolin does not increase SR Ca2+ leak.11 There-
fore, we carried out experiments to test for the second possibility of
Ca2+ spark activation, oxidative stress. Of note, redox modifications
of the RyRs are well known to increase their openings,43,44 although
direct RyR oxidation would not be sensitive to the CaMKII inhibitor
AIP, as observed in this study. Thus, we were left with the alternative
that an oxidative modification of CaMKII could be responsible for its ac-
tivation. However, we were unable to prevent the Ca2+ sparks with
Mn-TBAP, a SOD mimetic which we found to reliably suppress ROS
induced sparks in a model of oxidative stress.25 This finding suggests
that ROS generation afterb-AR stimulation is not involved in CaMKII ac-
tivation and is consistent with a recent report showing that ROS produc-
tion does not increase during b-AR stimulation of resting cells.45
4.3 NO activates CaMKII in
cardiomyocytes
An interesting observation has been reported in a study examining SR
Ca2+ leaks in cardiomyocytes duringb-AR stimulation using a dedicated
leak protocol.11 In this study, the SR Ca2+ leak has been quantified from
the drop of the cytosolic Ca2+ concentration after blocking the RyRs
with tetracaine. These authors showed that the function of CaMKII,
but also NO synthases, were important determinants for the SR Ca2+
leak.26 Surprisingly, our experiments along these lines revealed that
inhibition of NOS also prevented the increase in spark frequency, sug-
gesting an involvement of NO signalling. To confirm a key role of NO,
we useda multi-pronged approach.Wewereable todetect endogenous
NO production by the cardiomyocytes upon Iso application, while the
NO donor GSNO mimicked the effects of Iso on the spark frequency.
In contrast, the GSNO effect was almost completely inhibited by the
specific CaMKII inhibitor AIP, suggesting that direct RyR nitrosation
was not involved. Rather this appeared to be mainly mediated by
CaMKII. Could it be that NO maintains CaMKII active at resting Ca2+
concentrations, similar to what has been reported for ROS?23 For this
to occur, an initial Ca2+-dependent activation of CaMKII is required,
which could be mediated by invisible Ca2+ signals, such as the Ca2+
quarks suggested to underlie a fraction of the SR Ca2+ leak.46,47 To
address the intriguing question of NO-dependent CaMKII activation
directly, we applied a biochemical in vitro assay of CaMKII activity. The
results obtained confirmed that NO can maintain CaMKII active to an
extent similar toH2O2, without requiring elevated Ca
2+ concentrations.
Since this occurred in vitro and was initiated by significant S-nitrosation of
the CaMKII protein, it seems very likely that NO can directly activate
CaMKII. Interestingly, a strikingly different regulation by NO and ROS
has been reported for the CaMKIIa isoform of this kinase in pituitary
tumour GH3 cells. This isoform was inhibited after nitrosation, but
became activated in reducing conditions.48
4.4 Relevance of NO-dependent CaMKII
activation
Taken together, these findings provide compelling evidence for a stimu-
lation of endogenous NO generation by cardiomyocytes upon b-AR
stimulation. In the beating heart, this presumably additive mechanism
may be even more pronounced, since further CaMKII activation will
occur by enhanced Ca2+ transients. Several studies have previously
reported positive or negative inotropic effects of NO, which may be
partly related to modifications of CaMKII and RyR function, involved
NOS isoforms, or crosstalk between activated pathways.49,50 Related
to this, it has been suggested that NO may have a biphasic effect on
RyR open probability, depending on the extent of pre-existing b-AR
stimulation.51 Although the precise mechanism of this phenomenon
remains unresolved, it may involve CaMKII and could be related to
changes of the nitroso/redox balance, as several post-translational
modifications will modulate RyR function in an exceedingly complex
fashion.52
The pathway characterized here represents a newly discovered
mechanism for CaMKII activation. This results in a surge of diastolic
Ca2+ sparks and increased wave propensity. Since Ca2+ sparks are
signals faithfully reporting the function of the RyRs, this likely occurs
via CaMKII-dependent modulation of the RyRs. In addition, the direct
activation of CaMKII by NO observed here and the pathways participat-
ing downstream of CaMKII are expected to have additional repercus-
sions for cardiomyocyte Ca2+ signalling. For example, NO-mediated
CaMKII activation contributes to the modulation of Ca2+ cycling upon
b-AR stimulation, such as during physical exercise or emotional stress.
During sustained b-AR stimulation, such as during heart failure,
this could lead to SR Ca2+ depletion, weaker heartbeat, and
NO-dependent CaMKII activation 399
arrhythmias.40,53 The additional CaMKII activation prompted by NO
may be particularly detrimental if it occurs in conditions with already
hypersensitive RyRs, for example in the presence of CPVT mutations
or oxidative RyR modifications.
Finally, the identification of this pathway adds to the experimental
complexity of studies with cardiac muscle because it represents a possi-
bility for crosstalk between PKA and CaMKII activation, downstream of
b-ARstimulation.The existenceof such across-talk mayexplain some of
the controversial experimental results and interpretations regarding the
regulation of the RyRs by PKA or CaMKII, respectively.
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